Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant (STARS-ADHD Adjunctive)

NCT03649074 is registered in ClinicalTrials.gov with Akili Interactive Labs, Inc. as lead sponsor.

NCT NCT03649074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03649074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant (STARS-ADHD Adjunctive)
Lead sponsor
Akili Interactive Labs, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 28, 2018
Completion date
September 23, 2019
Enrollment
206 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder